Pura Vida Investments, LLC Exelixis, Inc. Transaction History

Pura Vida Investments, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$17.44 - $23.16 $1.31 Million - $1.74 Million	75,000 New	75,000 $1.56 Million
Q3 2021 Nov 15, 2021	SELL	$16.3 - $21.14 $843,997 - $1.09 Million	-51,779 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$17.95 - $25.56 $263,523 - $375,246	-14,681 Reduced 22.09%	51,779 $943,000
Q1 2021 May 12, 2021	BUY	$20.53 - $25.22 $1.36 Million - $1.68 Million	66,460 New	66,460 $1.5 Million
Q1 2019 May 14, 2019	SELL	$19.6 - $24.76 $1.69 Million - $2.13 Million	-86,055 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$13.65 - $21.8 $1.17 Million - $1.87 Million	85,735 Added 26792.19%	86,055 $1.69 Million
Q3 2018 Nov 14, 2018	BUY	$15.87 - $22.4 $5,078 - $7,168	320 New	320 $6,000
Q2 2018 Aug 14, 2018	SELL	$18.56 - $22.45 $742,400 - $898,000	-40,000 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$22.15 - $31.89 $886,000 - $1.28 Million	-40,000 Reduced 50.0%	40,000 $0
Q4 2017 Feb 14, 2018	BUY	$24.23 - $30.93 $1.94 Million - $2.47 Million	80,000	80,000 $0

503

244M

2.54M

2.29M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.6B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Pura Vida Investments, LLC with notifications on news.